Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche
- PMID: 35814384
- PMCID: PMC9258777
- DOI: 10.3389/fonc.2022.912060
Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche
Abstract
Megakaryocytes (MKs) are important components of the hematopoietic niche. Compared to the non-hematopoietic niche cells, MKs serving as part of the hematopoietic niche provides a mechanism for feedback regulation of hematopoietic stem cells (HSCs), in which HSC progeny (MKs) can modulate HSC adaptation to hematopoietic demands during both steady-state and stress hematopoiesis. MKs are often located adjacent to marrow sinusoids. Considering that most HSCs reside close to a marrow vascular sinusoid, as do MKs, the interactions between MKs and vascular endothelial cells are positioned to play important roles in modulating HSC function, and by extrapolation, might be dysregulated in various disease states. In this review, we discuss the interactions between MKs and the vascular niche in both normal and neoplastic hematopoiesis.
Keywords: hematopoietic microenvironment; hematopoietic stem cell (HSC); megakaryocyte (MK); myeloproliferative neoplasms; vascular niche.
Copyright © 2022 Zhan and Kaushansky.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm.Stem Cells. 2022 Apr 29;40(4):359-370. doi: 10.1093/stmcls/sxac005. Stem Cells. 2022. PMID: 35260895 Free PMC article.
-
Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin.Biochem Biophys Res Commun. 2014 Nov 14;454(2):353-7. doi: 10.1016/j.bbrc.2014.10.095. Epub 2014 Oct 24. Biochem Biophys Res Commun. 2014. PMID: 25451253
-
Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells.Nat Med. 2014 Nov;20(11):1321-6. doi: 10.1038/nm.3706. Epub 2014 Oct 19. Nat Med. 2014. PMID: 25326798
-
The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.Adv Biol Regul. 2018 Aug;69:11-15. doi: 10.1016/j.jbior.2018.06.003. Epub 2018 Jun 27. Adv Biol Regul. 2018. PMID: 29970351 Free PMC article. Review.
-
Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche.Leuk Res. 2016 Sep;48:107-12. doi: 10.1016/j.leukres.2015.12.012. Epub 2016 Jan 2. Leuk Res. 2016. PMID: 26803701 Review.
Cited by
-
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.Cancers (Basel). 2023 Aug 29;15(17):4323. doi: 10.3390/cancers15174323. Cancers (Basel). 2023. PMID: 37686599 Free PMC article. Review.
-
Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma.Biomolecules. 2023 Nov 7;13(11):1629. doi: 10.3390/biom13111629. Biomolecules. 2023. PMID: 38002311 Free PMC article. Review.
-
The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function.Cells. 2022 Nov 21;11(22):3704. doi: 10.3390/cells11223704. Cells. 2022. PMID: 36429131 Free PMC article. Review.
-
CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.Virchows Arch. 2024 May;484(5):837-845. doi: 10.1007/s00428-024-03799-4. Epub 2024 Apr 11. Virchows Arch. 2024. PMID: 38602559 Free PMC article.
-
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets.Int J Hematol. 2023 Mar;117(3):349-355. doi: 10.1007/s12185-022-03512-8. Epub 2022 Dec 27. Int J Hematol. 2023. PMID: 36574167 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources